Bridging treatment prior to liver transplantation for hepatocellular carcinoma: radioembolization or transarterial chemoembolization?
Abstract Background In hepatocellular carcinoma (HCC) patients, intraarterial therapies are regularly employed as a bridge to liver transplantation to prevent tumor progression during waiting time. Objective of this study was to compare HCC recurrence after liver transplantation following TACE or ra...
Main Authors: | Tamás Benkö, Julia König, Jens M. Theysohn, Clemens Schotten, Fuat H. Saner, Jürgen Treckmann, Sonia Radunz |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-05-01
|
Series: | European Journal of Medical Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40001-022-00708-w |
Similar Items
-
Yttrium-90 transarterial radioembolization versus conventional transarterial chemoembolization for patients with hepatocellular carcinoma: a systematic review and meta-analysis
by: Yi Yang, et al.
Published: (2018-09-01) -
Transarterial chemoembolization as an alternative to radioembolization is associated with earlier tumor recurrence than in radioembolization-eligible patients
by: Sung Won Chung, et al.
Published: (2023-02-01) -
Outcome of transarterial radioembolization in patients with hepatocellular carcinoma as a first-line interventional therapy and after a previous transarterial chemoembolization
by: Julia Wagenpfeil, et al.
Published: (2024-02-01) -
Transarterial radioembolization for hepatocellular carcinoma: a review
by: Sacco R, et al.
Published: (2016-07-01) -
Analysis of Periprocedural X-ray Exposure in Transarterial Radioembolization with Glass or Resin Microspheres
by: Constantin Ehrengut, et al.
Published: (2023-12-01)